Yulian Xu

The efficacy and safety of immune checkpoint inhibitor in patients with relapsed small‐cell lung cancer: A systematic review and meta‐analysis

Yanpeng Ding, Min S. Chen, Yulian Xu, 2021, Journal of clinical pharmacy and therapeutics.

Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA

Yahua Zhong, Gaili Chen, X. Hua, 2020, World Journal of Surgical Oncology.

Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma

H. Morse, Yulian Xu, J. Zhou, 2015, Oncotarget.

MT1X is an oncogene and indicates prognosis in ccRCC

R. Chen, Yanpeng Ding, Haijun Yu, 2022, Bioscience reports.

Ethylene Inhibits Anthocyanin Biosynthesis by Repressing the R2R3-MYB Regulator SlAN2-like in Tomato

Shuangshuang Yan, Zhengkun Qiu, Bihao Cao, 2022, International journal of molecular sciences.

Antitumor activity of orthogonal array designed extracts from different part of hedyotis diffusa on human hepatocellular carcinoma HepG 2

Yunlan Li, Qingshan Li, Yulian Xu, 2019 .

Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma

H. Morse, Yulian Xu, J. Zhou, 2014, Journal of Cancer.

Loss of IRF8 inhibits the growth of acute myeloid leukemia cells

Fengling Li, P. Ye, R. Pei, 2023, Annals of Hematology.